Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes

NCT00325650 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

2420

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision taken in light of demands by certain national health authorities

Conditions

Prediabetic State

Interventions

DRUG: Rimonabant
DRUG: Placebo (for Rimonabant)

Sponsor

Sanofi